The treatment of cocaine use disorder
Open accessThe DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.
Abstract
Current treatments for cocaine use disorder are often ineffective; new treatments are needed and are under development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Psychosocial/behavioral interventions-such as contingency management, community reinforcement, and cognitive behavioral therapy -remain the standard and most reliably available practices for treatment of MUD (36) and CUD (37).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contingency management for treatment of substance use disorders: a meta‐analysis
Prendergast, M., Podus, D., Finney, J., Greenwell, L., & Roll, J. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01581.x · Cited by 877
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
Kampman, K., & Jarvis, M. (2015) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000166 · Cited by 678
Self-citationScofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598
Glutamate Transmission in the Nucleus Accumbens Mediates Relapse in Cocaine Addiction
Cornish, J. L., & Kalivas, P. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0006.2000 · Cited by 545
Volkow, N. D., Fowler, J. S., Logan, J., Alexoff, D., Zhu, W., Telang, F., Wang, G.-J., Jayne, M., Hooker, J. M., Wong, C., et al. (2009) · JAMA · doi:10.1001/jama.2009.351 · Cited by 529
Give them prizes and they will come: Contingency management for treatment of alcohol dependence.
Petry, N. M., Martin, B., Cooney, J. L., & Kranzler, H. R. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.250 · Cited by 515
Behavioral Therapies for Drug Abuse
Carroll, K. M., & Onken, L. S. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1452 · Cited by 459
Carroll, K. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950120061010 · Cited by 409
Carroll, K. M., Ball, S. A., Martino, S., Nich, C., Babuscio, T. A., Nuro, K. F., Gordon, M. A., Portnoy, G. A., & Rounsaville, B. J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07111835 · Cited by 405
Cited by
Microneedle patch for the ultrasensitive quantification of protein biomarkers in interstitial fluid
Wang, Z., Luan, J., Seth, A., Liu, L., You, M., Gupta, P., Rathi, P., Wang, Y., Cao, S., Jiang, Q., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-020-00672-y · Cited by 386
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“It is also suggested that individuals suffering from obesity and individuals suffering from addiction have overlapping brain dysregulations, and the anti-obesity effects of GLP-1 receptor agonists support the potential usefulness of GLP-1 receptor agonists for the treatment of SUD and AUD.”
BackgroundInfluentialThe Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms
Jones, C. M., Bekheet, F., Park, J. N., & Alexander, G. C. (2020) · Epidemiologic Reviews · doi:10.1093/epirev/mxaa011 · Cited by 188
Roque Bravo, R., Faria, A. C., Brito-da-Costa, A. M., Carmo, H., Mladěnka, P., Dias da Silva, D., Remião, F., & Researchers, O. B. O. T. O. (2022) · Toxins · doi:10.3390/toxins14040278 · Cited by 161
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05563-3 · Cited by 151
Metadata
- Authors
- Kampman, K. M.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Kampman, Kyle M.
- ORCID
- Kampman, Kyle M.
- Venue
- Science Advances
- Published
- 2019-10-11
- Volume
- 5
- Issue
- 10
- Pages
- eaax1532-eaax1532
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6795516
- OpenAlex
- W2981018657
- Cited by
- 250
- References
- 71
- Citations by year
- 2026: 34 · 2025: 45 · 2024: 43 · 2023: 41 · 2022: 47 · 2021: 28 · 2020: 12
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- cocaine dependence, cocaine addiction treatment, psychosocial interventions, contingency management, cognitive behavioral therapy, drug augmentation, dopamine agonists, modafinil, topiramate, glutamatergic agents, GABAergic agents, combination drugs
- MeSH terms
- Animals, Cocaine, Humans, United States, Dopamine Agonists, Cocaine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.